TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,619,015 | -66.3% | 13,471,174 | +0.1% | 0.00% | -62.5% |
| Q2 2023 | $334,224,684 | +66.1% | 13,455,100 | +0.6% | 0.01% | +60.0% |
| Q1 2023 | $201,227,785 | +9.7% | 13,379,507 | -13.7% | 0.01% | 0.0% |
| Q4 2022 | $183,397,698 | +110.1% | 15,502,764 | +5.1% | 0.01% | +66.7% |
| Q3 2022 | $87,299,000 | +57.8% | 14,746,392 | +13.3% | 0.00% | +50.0% |
| Q2 2022 | $55,339,000 | -52.0% | 13,020,832 | +7.3% | 0.00% | -33.3% |
| Q1 2022 | $115,366,000 | -49.8% | 12,130,963 | +0.3% | 0.00% | -40.0% |
| Q4 2021 | $229,738,000 | -42.6% | 12,091,437 | +0.5% | 0.01% | -50.0% |
| Q3 2021 | $400,438,000 | -12.0% | 12,032,376 | +2.6% | 0.01% | -9.1% |
| Q2 2021 | $454,826,000 | -15.2% | 11,725,344 | +5.4% | 0.01% | -26.7% |
| Q1 2021 | $536,194,000 | -6.0% | 11,124,376 | +1.4% | 0.02% | -11.8% |
| Q4 2020 | $570,703,000 | +184.8% | 10,970,863 | +46.5% | 0.02% | +142.9% |
| Q3 2020 | $200,381,000 | +88.3% | 7,488,077 | +37.1% | 0.01% | +75.0% |
| Q2 2020 | $106,389,000 | +142.7% | 5,461,470 | +22.6% | 0.00% | +100.0% |
| Q1 2020 | $43,830,000 | -6.9% | 4,454,226 | +5.0% | 0.00% | 0.0% |
| Q4 2019 | $47,092,000 | +114.0% | 4,242,519 | +8.2% | 0.00% | +100.0% |
| Q3 2019 | $22,008,000 | -37.0% | 3,919,492 | -3.0% | 0.00% | 0.0% |
| Q2 2019 | $34,955,000 | +28.8% | 4,041,122 | +19.7% | 0.00% | 0.0% |
| Q1 2019 | $27,142,000 | +234.4% | 3,375,742 | +70.5% | 0.00% | – |
| Q4 2018 | $8,117,000 | -52.6% | 1,979,668 | -35.3% | 0.00% | -100.0% |
| Q3 2018 | $17,125,000 | -53.3% | 3,058,080 | +9.6% | 0.00% | -50.0% |
| Q2 2018 | $36,683,000 | +1.4% | 2,789,597 | +9.5% | 0.00% | 0.0% |
| Q1 2018 | $36,191,000 | +81.9% | 2,548,704 | +5.1% | 0.00% | +100.0% |
| Q4 2017 | $19,891,000 | -25.8% | 2,425,710 | +7.2% | 0.00% | 0.0% |
| Q3 2017 | $26,811,000 | +30.4% | 2,262,507 | +10.6% | 0.00% | 0.0% |
| Q2 2017 | $20,566,000 | -1.4% | 2,046,427 | +14.3% | 0.00% | 0.0% |
| Q1 2017 | $20,860,000 | +190.5% | 1,790,583 | +16.0% | 0.00% | – |
| Q4 2016 | $7,181,000 | -37.6% | 1,544,179 | +3.8% | 0.00% | -100.0% |
| Q3 2016 | $11,512,000 | +28.0% | 1,487,322 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $8,995,000 | -20.7% | 1,484,133 | +11.5% | 0.00% | 0.0% |
| Q1 2016 | $11,344,000 | -23.9% | 1,331,433 | +6.5% | 0.00% | 0.0% |
| Q4 2015 | $14,912,000 | +21.1% | 1,250,034 | +2.3% | 0.00% | – |
| Q3 2015 | $12,318,000 | -32.3% | 1,222,023 | +11.3% | 0.00% | -100.0% |
| Q2 2015 | $18,208,000 | +10.2% | 1,097,494 | +2.9% | 0.00% | 0.0% |
| Q1 2015 | $16,517,000 | -0.4% | 1,066,992 | +1.9% | 0.00% | 0.0% |
| Q4 2014 | $16,584,000 | +87.3% | 1,046,968 | +26.2% | 0.00% | 0.0% |
| Q3 2014 | $8,854,000 | +22.6% | 829,773 | +7.9% | 0.00% | 0.0% |
| Q2 2014 | $7,221,000 | +42.8% | 769,030 | +4.9% | 0.00% | – |
| Q1 2014 | $5,057,000 | +92.6% | 732,982 | +8.9% | 0.00% | – |
| Q4 2013 | $2,626,000 | +561.5% | 673,161 | +763.7% | 0.00% | – |
| Q3 2013 | $397,000 | +124.3% | 77,936 | +182.2% | 0.00% | – |
| Q2 2013 | $177,000 | – | 27,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |